Patent application number | Description | Published |
20090125348 | METHODS FOR GENERATING HEALTHCARE PROVIDER QUALITY AND COST RATING DATA - A computer-implemented method for generating healthcare provider quality rating data from healthcare claim records representing services provided by a plurality of healthcare providers (such as physicians or hospitals) to one or more patients includes grouping the claim records into one or more claim groups, each representing services provided to a patient by one or more providers; assigning each claim group to a responsible provider; assessing the claim records in each claim group using guidelines for the particular disease or condition and generating a compliance score for the claim group, wherein the compliance score indicates the extent to which the claim records in the claim group match the guidelines; and generating provider quality rating data for each provider using the normalized aggregate compliance score. The provider quality rating data may include one or more performance categories or graphic symbols that indicate the provider's quality of treatment in comparison to an average value. Provider volume data may also be generated. | 05-14-2009 |
20120116985 | METHODS FOR GENERATING HEALTHCARE PROVIDER QUALITY AND COST RATING DATA - A method for generating healthcare provider quality rating data includes grouping claim records into one or more claim groups, assigning each claim group to a responsible provider, assessing the claim records in each claim group using guidelines for the particular disease or condition, and generating a compliance score for the claim group, wherein the compliance score indicates the extent to which the claim records in the claim group match the guidelines, and generating normalized provider quality rating data. A method for generating healthcare provider cost rating data includes grouping claim records into one or more claim groups, assigning each claim group to a responsible provider, calculating the total cost of each claim group, aggregating the total cost for each claim group, and comparing the total aggregate cost of each claim group assigned to each provider to an expected cost value. | 05-10-2012 |
20150039330 | EPISODE OF CARE BUILDER METHOD AND SYSTEM - The Episode Builder according to exemplary embodiments of the present invention is a web-based computer application and its associated architecture that allows health care professionals to define and describe episodes of care. The Episode Builder provides a unique tool for these purposes. Using industry-standard code sets, the Episode Builder describes and defines an episode of care so that the health care professional can create and modify episodes for a variety of purposes. The three main components of the Episode Builder are a configurable and extensive code set management system, a suite of display panels that define the episodes themselves based upon the code sets, and a means to export the episode definition tables thus created to be used as inputs into an analytic program or a claims adjudication engine. | 02-05-2015 |
Patent application number | Description | Published |
20130212386 | Storage Access Authentication Mechanism - In embodiments according to the present invention an encryption switch is used to authorize access to LUNs from client VMs present in the cloud provider network. The encryption switch includes responder side software for an authentication protocol and an agent in the client VM includes the requestor side of the authentication protocol. The certificate of the client is securely provided to the encryption switch, which associates the client VM with the LUN. The client private key is securely provided to the client VM, which retains it only non-persistently. The client VM requests LUN access and performs an authentication handshake with the encryption switch. If successful the client VM than has access to the LUN. As the original certificate is linked to the client, if the client is itself a VM, should the client be moved to a different host, the certificate moves with it and LUN accessibility is maintained. | 08-15-2013 |
20130219169 | Public Cloud Data at Rest Security - An encryption switch which is used in a cloud environment to secure data on the LUNs used by the clients. A client provides a certificate to the cloud service. The encryption switch develops a cloud crypto domain (CCD) as a secure area, with the data at rest on the LUNs encrypted. The encryption switch develops a master key for client use in the CCD, which is provided to the client encrypted by the client's public key. Data encryption keys (DEKs) are created for each LUN and provided to the client. The DEKs are stored in a key vault by the client for use if needed. The cloud service provisions a client VM to be used with the encrypted LUN and develops a nexus between the LUN and the client VM for the encryption switch to use in data operations. The client communicates through the client VM to access the LUN. | 08-22-2013 |
20150288567 | FRAMEWORK FOR RELIABLY COMMUNICATING PORT INFORMATION IN A SYSTEM OF DEVICES - A framework for reliably communicating port information in a system of devices is provided. In one embodiment, each device in the system of devices can create a first record that includes port information pertaining to a plurality of ports of the device, where the plurality of ports are usable for communicatively coupling the device to other devices in the system of devices. The device can further receive, from the other devices in the system of devices, one or more second records including port information pertaining to the ports of the other devices, and can store the first record and the one or more second records in a data store maintained locally on the device. The device can then forward copies of the first record and the one or more second records out of each of the plurality of ports, thereby causing the copies of the first record and the one or more second records to be communicated to the other devices in the system of devices. | 10-08-2015 |
Patent application number | Description | Published |
20120130300 | Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics - An injectable or implantable medical device having orifice(s) on the surface that release an active agent with zero-order release kinetics is described herein. The device is a hollow matrix of any size or shape, which can be made from both metal and non-metal surfaces. The device comprises of a reservoir capable of releasing at least one therapeutic, diagnostic, or prophylactic agent via the orifices to the desired anatomical site. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to zero-order release kinetics for most of the time. The composition provides zero-order kinetics, in part, because the diffusion rate of the drug from the device is slow which enables sink conditions. Hence, no back transfer or build up of drug occurs at anytime. Polymers are not required for controlled release. | 05-24-2012 |
20120177716 | Methods for Making Controlled Delivery Devices Having Zero Order Kinetics - A method of making an injectable or implantable active agent delivery device capable of delivering a diagnostic, therapeutic, and/or prophylactic agent to a desired targeted site having orifice(s) on the surface is disclosed herein providing unidirectional release of the agent at a controlled desirable rate. The agent may include, but is not limited to, drugs, proteins, peptides, biomarkers, bioanalytes, and/or genetic material. The technology of the invention is based on parallel processing to fabricate micro-holes on tubes employing photo-lithography and reactive ion etching techniques and also incorporates a simple molding method to form the micro-holes on flexible polymer tubes, including bio-degradable tubes. The parallel processing method of the instant invention is fast, economical and well suited for mass production. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to zero-order release kinetics for most of the time. | 07-12-2012 |
20150208982 | Methods for Making Controlled Delivery Devices Having Zero Order Kinetics - A method of making an injectable or implantable active agent delivery device capable of delivering a diagnostic, therapeutic, and/or prophylactic agent to a desired targeted site having orifice(s) on the surface is disclosed herein providing unidirectional release of the agent at a controlled desirable rate. The agent may include, but is not limited to, drugs, proteins, peptides, biomarkers, bioanalytes, and/or genetic material. The technology of the invention is based on parallel processing to fabricate micro-holes on tubes employing photo-lithography and reactive ion etching techniques and also incorporates a simple molding method to form the micro-holes on flexible polymer tubes, including bio-degradable tubes. The parallel processing method of the instant invention is fast, economical and well suited for mass production. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to zero-order release kinetics for most of the time. | 07-30-2015 |
Patent application number | Description | Published |
20090094354 | TECHNIQUE FOR IMPLEMENTING VIRTUAL FABRIC MEMBERSHIP ASSIGNMENTS FOR DEVICES IN A STORAGE AREA NETWORK - A technique is provided for facilitating fabric membership login for an N_Port of a storage area network. A communication from a network node is received. The communication may include a portion of criteria associated with the N_Port. Using at least a portion of the portion of criteria, a virtual fabric identifier corresponding to a virtual fabric which is associated with the N_Port may be automatically identified. Fabric configuration information, which includes the virtual fabric identifier, may be automatically provided to the network node. A fabric login request from the N_Port to login to the virtual fabric may then be received. According to a specific embodiment, the communication may be transmitted from a network node to an F_Port on a Fibre Channel switch. When the N_Port received the fabric configuration information from the F_Port, the generating, using at least a portion of the received fabric configuration information, a fabric login request message may be generated by the N_Port which includes a fabric login request for the N_Port to login to the virtual fabric corresponding to the virtual fabric identifier. In at least one implementation, the N_Port and/or F_Port may be configured or designed to support trunking functionality. | 04-09-2009 |
20090103566 | SWITCH PORT ANALYZERS - Methods and devices are provided for non-disruptive monitoring of network traffic through one or more ports of a Fibre Channel network device. Preferred embodiments of the invention are used in conjunction with the switched port analyzer (“SPAN”) and/or remote SPAN (“RSPAN”) features. SPAN mode operation allows traffic through any Fibre Channel interface of a network device to be replicated and delivered to a single port on the same network device. Ingress SPAN allows the monitoring of some or all packets that ingress a specified port or ports. Egress SPAN allows the monitoring of some or all packets that egress a specified port or ports. RSPAN allows the delivery of the replicated traffic to a port on a remote network device. Filtering may be applied, for example, to SPAN packets having selected virtual storage area network numbers. | 04-23-2009 |
20120207177 | VIRTUAL PORT BASED SPAN - Methods and apparatus for performing SPAN for a virtual port are disclosed. Specifically, a frame is received from a first port. The frame or a copy thereof is transmitted to a second port, where the second port is identified in a header of the frame. At least one of the first port and the second port is a virtual port. The frame or a copy thereof is also transmitted to a third port, thereby enabling an analyzer coupled to the third port to analyze traffic received by the third port. | 08-16-2012 |
20150023361 | TECHNIQUE FOR IMPLEMENTING VIRTUAL FABRIC MEMBERSHIP ASSIGNMENTS FOR DEVICES IN A STORAGE AREA NETWORK - A technique is provided for facilitating fabric membership login for an N_Port of a storage area network. A communication from a network node is received. The communication may include a portion of criteria associated with the N_Port. Using at least a portion of the portion of criteria, a virtual fabric identifier corresponding to a virtual fabric which is associated with the N_Port may be automatically identified. Fabric configuration information, which includes the virtual fabric identifier, may be automatically provided to the network node. A fabric login request from the N_Port to login to the virtual fabric may then be received. According to a specific embodiment, the communication may be transmitted from a network node to an F_Port on a Fibre Channel switch. When the N_Port received the fabric configuration information from the F_Port, the generating, using at least a portion of the received fabric configuration information, a fabric login request message may be generated by the N_Port which includes a fabric login request for the N_Port to login to the virtual fabric corresponding to the virtual fabric identifier. In at least one implementation, the N_Port and/or F_Port may be configured or designed to support trunking functionality. | 01-22-2015 |
Patent application number | Description | Published |
20080258672 | METHOD OF STARTING A SYNCHRONOUS MOTOR WITH A BRUSHLESS DC EXCITER - A starting method and system for a motor where the motor may be started as an induction motor by applying a magnetizing current to build flux through the stator, with the field current set at the maximum permissible exciter stator current (i.e., the current that will cause rated no-load current in the main field at the transition speed). The motor stator currents will be maintained at a value that allows the motor to generate sufficient breakaway torque to overcome any stiction. At a specific transition speed or after a period of time, the drive will initiate a transition from induction motor control to synchronous motor control by removing the initial magnetizing current, and a field current is then applied to the motor through the DC exciter. Once this transition is completed, the drive may ramp up to the desired speed demand. | 10-23-2008 |
20090058584 | THREE-PHASE MULTI-WINDING DEVICE - A three-phase, multi-winding includes a core, the core including a hub and an outer shell around a perimeter of the hub. wherein the hub and the outer shell are in a fixed position with respect to each other. The core also includes multiple slots. In addition to the core, the multi-winding device includes a primary winding positioned in at least two of the slots; and multiple spatially distributed secondary windings, wherein at least one of the secondary windings is positioned proximate the primary winding in at least one of the two slots. | 03-05-2009 |
20090302682 | METHOD AND SYSTEM FOR REDUCING SWITCHING LOSSES IN A HIGH-FREQUENCY MULTI-CELL POWER SUPPLY - A method of reducing switching losses in a power supply includes the steps of advancing the output voltage of a first pole of a power cell by a first angle, retarding the output voltage of a second pole of the power cell by a second angle, and producing a combined output voltage of the power cell equal to a positive pulse of a duration angle equal to the sum of the first angle and the second angle for a first half of a switching cycle of the power cell, and equal to a negative pulse of a duration angle equal to the sum of the first angle and the second angle for a second half of the switching cycle of the power cell. | 12-10-2009 |
20140063871 | POWER DELIVERY SYSTEMS AND METHODS FOR OFFSHORE APPLICATIONS - A system for delivering power to an offshore load is disclosed. The system may include an on-land source of three-phase power, an on-land AC-to-DC power conversion module, a DC transmission line, and an offshore DC-to-AC power inverter. The on-land AC-to-DC power conversion module may be configured to convert the three-phase power to DC power. The DC transmission line may have a source end and a load end, where the source end is configured to receive DC power from the on-land AC-to-DC power conversion module. The offshore DC-to-AC power inverter may be configured to receive DC power from the DC transmission line, convert the DC power to three-phase AC power, and deliver the three-phase AC power to an offshore load. | 03-06-2014 |
20140210431 | APPARATUS AND METHODS FOR FEEDBACK SENSING IN MULTI-CELL POWER SUPPLIES - Apparatus and methods in accordance with this invention provide a multi-cell power supply for receiving power from a source and delivering power at an output terminal to a load. The multi-cell power supply includes a first power cell coupled to the source, and a first current sensor circuit. The first power cell provides a first output current, and includes a first output terminal coupled to a reference node of the multi-cell power supply, and a second output terminal coupled to the output terminal. The first current sensor circuit includes a first current sensor and a power supply. The first current sensor is coupled to the first output terminal of the first power cell, and measures the first output current. The power supply is coupled to either the reference node or a floating ground node of the first power cell, and provides power to the first current sensor. | 07-31-2014 |
Patent application number | Description | Published |
20080197017 | Target/Backing Plate Constructions, and Methods of Forming Them - The Invention includes target/backing plate constructions and methods of forming target/backing plate constructions. The targets and backing plates can be bonded to one another through an appropriate interlayer. The targets can comprise one or more of aluminum, copper, tantalum and titanium. The interlayer can comprise one or more of silver, copper, nickel, tin, titanium and indium. Target/backing plate constructions of the present invention can have bond strengths of at least 20 ksi and an average grain size within the target of less than 80 microns. | 08-21-2008 |
20080291634 | THERMAL INTERCONNECT AND INTERFACE MATERIALS, METHODS OF PRODUCTION AND USES THEREOF - Thermal interface materials are disclosed that include at least one matrix material component, at least one high conductivity filler component, at least one solder material; and at least one material modification agent, wherein the at least one material modification agent improves the thermal performance, compatibility, physical quality or a combination thereof of the thermal interface material. Methods of forming thermal interface materials are also disclosed that include providing each of the at least one matrix material component, at least one high conductivity filler, at least one solder material and at least one material modification agent, blending the components; and optionally curing the components pre- or post-application of the thermal interface material to the surface, substrate or component. Also, thermal interface materials are disclosed that include at least one matrix material component, at least one high conductivity filler component, at least one solder material; and at least one material modification agent, wherein the at least one material modification agent at least one modified thermal filler profile. | 11-27-2008 |
20090078570 | TARGET/BACKING PLATE CONSTRUCTIONS, AND METHODS OF FORMING TARGET/BACKING PLATE CONSTRUCTIONS - Target/backing plate constructions and methods of forming target/backing plate constructions are disclosed herein. The targets and backing plates can be bonded to one another through an appropriate interlayer. The targets can comprise one or more of titanium, tantalum, titanium zirconium, hafnium, niobium, vanadium, tungsten, copper or a combination thereof. The interlayer can comprise one or more of silver, copper, nickel, tin, titanium and indium. Target/backing plate constructions of the present invention can have bond strengths of at least 20 ksi and an average grain size within the target of less than 80 microns. | 03-26-2009 |
Patent application number | Description | Published |
20090126318 | Packaging Solutions - A packaging system for the storage of a hydrogel contact lens employs an aqueous solution including hydroxypropyl methylcellulose. | 05-21-2009 |
20090145461 | Degassing System - An ophthalmic device forming system includes an inspection station configured to receive a plurality of ophthalmic devices, a fluid supply fluidly connected to the inspection station, the fluid supply containing a working fluid, and a degassing assembly fluidly connected between the fluid supply and the inspection station. The degassing assembly comprises a housing, a vacuum device, and a membrane. The vacuum device is fluidly connected to the housing adjacent to the membrane. | 06-11-2009 |
20090326651 | Ophthalmic Device Formed by Additive Fabrication and Method Thereof - An ophthalmic device is formed by additive fabrication, the optical device having an optical surface with a surface roughness on the order of less than 10 microns. A method is provided for making an ophthalmic device including an optical surface having a surface roughness of less than 10 microns by depositing on a stage in a first relative position a first lamina of particulates having a size less than 10 microns and in select configurations less than two microns and certain configurations less than one micron, and, synergistically stimulating the first lamina of particulates to form a first solidified layer. | 12-31-2009 |
20150138499 | OPHTHALMIC DEVICE FORMED BY ADDITIVE FABRICATION AND METHOD THEREOF - An ophthalmic device is formed by additive fabrication, the optical device having an optical surface with a surface roughness on the order of less than 10 microns. A method is provided for making an ophthalmic device including an optical surface having a surface roughness of less than 10 microns by depositing on a stage in a first relative position a first lamina of particulates having a size less than 10 microns and in select configurations less than two microns and certain configurations less than one micron, and, synergistically stimulating the first lamina of particulates to form a first solidified layer. | 05-21-2015 |
Patent application number | Description | Published |
20120004318 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 01-05-2012 |
20120201889 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE - The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain. | 08-09-2012 |
20130011474 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE - The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain. | 01-10-2013 |
20130012593 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions, following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 01-10-2013 |
20130302430 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE - The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain. | 11-14-2013 |
20130310460 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 11-21-2013 |
20140213659 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 07-31-2014 |
20150148427 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 05-28-2015 |
20150258031 | MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS - The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment. | 09-17-2015 |
20150258042 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE - The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain. | 09-17-2015 |